The HEALTH : October 2019 | Page 9

OctOber, 2019 | The HealTH HealtH Business 09 C OULD you give us an overview on the state of halal pharma- ceuticals and cosmetics in Malaysia? What is the public perception towards it, and how much of an advantage is it to have halal-certifi ed pharmaceuticals and cosmetics? As an overview on the state of halal pharma- ceuticals and cosmetics in Malaysia in terms of statements from professional bodies, the Ministry and Industry is cautiously welcoming and looking forward to further developments, especially related to the devel- opment and application of halal standards. Ultimately the consumer or patient will decide on the type of products off ered to them that is compatible to their religious and health needs. Th e more they are provided information on halal medicines, the better is their confi dence in making a decision. Th e easy access to social media and the internet have paved the way to the type of perception a particular product is projected and compared to generic or similar products. We know that there has been a Malaysian Standard for halal pharmaceuticals, the MS2424:2012. How involved were you in the development of the standard, and what is the current development in terms of updating the standard? Th e world fi rst halal pharmaceutical standard the Malaysian MS 2424:2012 Halal Pharma- ceutical Guidelines was launched in 2012 and was well received. Being the chairman, it took the committee more than two years to formulate the document, having the vital input from the Malaysian regulatory body recommending the internationally recognised PICS (Pharmaceutical Inspection Cooperative Scheme) format suited for pharmaceutical products. Halal elements were embedded into the document and a revision was established recently and renamed MS2424:2019 Halal Pharmaceutical Requirements, with further improvements and addition of halal vaccine standard. We anticipate further additions to include pharmaceutical intoxicants and biopharmaceuticals to cater and prepare to the need and demand of relevant standards. From the extent of my knowledge, Malaysia is the fi rst to set a standard and have pharmaceuticals and cosmetics be halal-certifi ed. In your opinion, how far along is Malaysia in terms of leading the global halal industry specifi cally in halal pharmaceuticals? Recently we [the Malaysian Halal Standard committee] were tasked to establish and lead the TC (Technical Committee) on Halal Pharmaceutical in Istanbul, Turkey. Th is com- mittee is incorporated under the SMIIC/OIC (Standards and Metrology Institute of Islamic Countries under the auspices of the Organisa- tion of Islamic Countries). It is an honour and recognition for Malaysian Standards and this opens the way for Malaysia to lead the global halal industry for pharmaceuticals. The state of halal pharma in Malaysia Prof Dr Zhari Ismail tells the strength of establishing halal standard and guideline for our medication. Do you think that because of the halal certifi cation, the Muslim public would be more cautious and doubtful of phar- maceuticals that are not halal-certifi ed? A positive attitude is that we should not take things lightly in matters related to our health & consumer needs. Th is attitude of learning and sharing approach towards medicine taking and shared responsibility with the health professionals is the future in health- care. In the United Kingdom since 2002, the concept of concordance-or shared decision making was promoted to help patients to get the most from their medicines that was established under the Medicines Partnership Programme. And as an extension to that ques- tion: What would be your opinion on medications that actually have non-halal ingredients to be consumed by Muslims, if it is the only one that can treat a par- ticular disease? Under this category of medicines, the Ministry of Health have specifi c guidelines on medicine taking of non-halal ingredients and this is widely available for use by all concerned. Dr Zhari was the chairman for the committee that formulated the Ms2424, the standard for halal pharmaceuticals. In five to 10 year’s time, do you see MS2424 to be the medium that can propel Malaysia into becoming the global leader in halal pharmaceuticals? Malaysia’s eff orts have been recognised and now being entrusted the important task in chairing the TC on Halal Pharmaceutical Issues within SMIIC/OIC. Th e MS2424:2019 is not a standalone documents, but must be supported by reference documents like pharmacopoeia and formularies that are shariah compliant. Th e agenda is long and sincere continuous effort have to be in place especially in engaging the multina- tional players to facilitate and activate their role to the needs of the Ummah. — The Health